PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 214 filers reported holding PACIRA PHARMACEUTICALS INC in Q4 2015. The put-call ratio across all filers is 1.83 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $11,274,120 | -27.4% | 292,000 | 0.0% | 0.23% | -24.6% |
Q3 2022 | $15,531,000 | -8.8% | 292,000 | 0.0% | 0.31% | -12.0% |
Q2 2022 | $17,024,000 | -52.6% | 292,000 | -51.0% | 0.35% | -53.4% |
Q4 2021 | $35,882,000 | -33.8% | 596,338 | -38.3% | 0.75% | -28.8% |
Q3 2021 | $54,165,000 | -22.2% | 967,236 | -15.7% | 1.06% | -14.5% |
Q2 2021 | $69,600,000 | -14.8% | 1,147,000 | -1.5% | 1.24% | -28.0% |
Q1 2021 | $81,653,000 | +30.0% | 1,164,973 | +11.0% | 1.72% | +38.3% |
Q4 2020 | $62,811,000 | -12.8% | 1,049,647 | -12.4% | 1.24% | -29.2% |
Q3 2020 | $72,013,000 | -17.5% | 1,197,825 | -28.0% | 1.75% | -31.0% |
Q2 2020 | $87,258,000 | +59.9% | 1,663,000 | +2.2% | 2.54% | +46.7% |
Q1 2020 | $54,571,000 | +3134.8% | 1,627,521 | +3155.0% | 1.73% | +2524.2% |
Q2 2016 | $1,687,000 | -94.1% | 50,000 | -86.5% | 0.07% | -94.3% |
Q4 2015 | $28,489,000 | -1.3% | 371,000 | -47.2% | 1.16% | +3.4% |
Q3 2015 | $28,872,000 | +92.6% | 702,485 | +231.4% | 1.12% | +123.8% |
Q2 2015 | $14,993,000 | – | 212,000 | – | 0.50% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Prosight Management, LP | 1,210,377 | $37,134,366 | 11.77% |
Gagnon Advisors, LLC | 180,331 | $5,532,555 | 4.63% |
GAGNON SECURITIES LLC | 565,429 | $17,347,361 | 4.35% |
ARDSLEY ADVISORY PARTNERS LP | 310,000 | $9,510,800 | 2.12% |
RICE HALL JAMES & ASSOCIATES, LLC | 968,485 | $29,713,120 | 1.89% |
AlphaCentric Advisors LLC | 103,000 | $3,160,040 | 1.79% |
1492 Capital Management LLC | 79,687 | $2,444,797 | 1.58% |
ARDSLEY ADVISORY PARTNERS LP | 149,000 | $4,571,320 | 1.02% |
OUTFITTER FINANCIAL LLC | 32,305 | $991,117 | 0.93% |
Rock Springs Capital Management LP | 1,055,500 | $32,382,740 | 0.87% |